Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
AR Marra, T Kobayashi, H Suzuki… - Journal of …, 2022 - journalofinfection.com
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
[HTML][HTML] Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
AR Marra, T Kobayashi, H Suzuki… - The Journal of …, 2022 - ncbi.nlm.nih.gov
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
AR Marra, T Kobayashi, H Suzuki… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
[PDF][PDF] Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
AR Marra, T Kobayashi, H Suzuki, M Alsuhaibani… - Journal of …, 2022 - binasss.sa.cr
Objectives: We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
[引用][C] Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
AR Marra, T Kobayashi, H Suzuki, M Alsuhaibani… - Journal of …, 2022 - cir.nii.ac.jp
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic
literature review and meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報 …
literature review and meta-analysis | CiNii Research CiNii 国立情報学研究所 学術情報 …
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
AR Marra, T Kobayashi, H Suzuki… - The Journal of …, 2022 - iro.uiowa.edu
We performed a systematic review and meta-analysis of 33 observational studies.• All
COVID-19 vaccine studies compared immunocompromised patients vs. control group.• …
COVID-19 vaccine studies compared immunocompromised patients vs. control group.• …
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis.
AR Marra, T Kobayashi, H Suzuki… - The Journal of …, 2022 - europepmc.org
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis.
AR Marra, T Kobayashi, H Suzuki… - The Journal of …, 2022 - europepmc.org
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
[HTML][HTML] Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
AR Marra, T Kobayashi, H Suzuki… - Journal of …, 2022 - journalofinfection.com
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …